Trend analysis of gastric cancer incidence in Iran and its six: Geographical areas during 2000-2005

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3335-3341

  Haidari, Mohmmad ^a   Nikbakht, Mohammad Reza ^a   Pasdar, Yahya ^a   Najafi, Farid ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gastric cancer; Geographical regions; Incidence; Iran; Trend

Indexed keywords

EID: 84873573961     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3335     Document Type: Article

References (58)

1. Al-Marhoon M S, Nunn S, Soames R W (2004).The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model. Dig Dis Sci, 49, 1116-22.
2. American Cancer Society (2009). Cancer Facts & Figures. ACS, ?, 2-6 Atherton J C (2006). The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annu Rev Patho, 1, 63-96.
3. Babaei M, Mousavi S, Malek M (2005).Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pacific J Cancer Prev, 6, 159-64.
4. Bafandeh Y, Farhang S, (2009).Subsite distribution of gastric cancer in an area of high prevalence-northwest Iran. J Epidemiol, 19, 202-5.
5. Botterweck A, Schouten L J, Volovics A (2000). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29, 645-54.
6. Boyle P, Dore J, Autier P (2004). Cancer of the skin: a forgotten problem in Europe. Ann Oncol, 15, 5-6.
7. Brunetti D, Tamaro P, Tiribelli M (2009). Time trend in cancer incidence among 0-24 year-old residents of the Province of Trieste, Italy, 1972-2003. Epidemiol Prev, 33,161-8
8. Center for Disease Control and Prevention NDCO (2007). Iranian Annual National Cancer Registration Report 2005 - 2006[in Persian]. Ministry of Health and Medical Education Press, Tehran pp 10-13.
9. Chandanos E, Lagergren J (2008). Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer, 44, 2397-03.
10. Fritz A, Percy C, Jack A, et al (2000). International Classification of Disease for Oncology, WHO, Geneva Alikhani S, Delavari A, Alaedini F, et al (2009). A provincebased surveillance system for the risk factors of noncommunicable diseases: a prototype for integration of risk factor surveillance into primary healthcare systems of developing countries. Public Health, 123, 358-64.
11. A National Profile of Non communicable Disease Risk Factors in the I.R.Iran (2005). Persian, 1, 33-55
12. Derakhshan M H, Malekzadeh R, Watabe H, et al (2007). Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut, 10, 298-05.
13. Eskandar H, Hossein S, Rahim M, et al (2006). Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol, 12, 4832-5.
14. Cabanes A, Vidal E, Aragonés N, et al (2010). Cancer mortality trends in Spain: 1980-2007. Ann Oncol, 3,14-20.
15. Etemadi A, Sajdadi A, Semnani S, et al (2008). Cancer registry in Iran: a brief overview. Arch Iran Med, 11, 577-80.
16. Fabrizio S, Antonio C (2007).Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis. BioMed Central Ltd, 7, 1-9.
17. Forman D, Coleman M (1993). An internationalassociation between Helicobacter pylori infection and gastric cancer. Lancet, 341, 1359-62.
18. Fuchs CS, Mayer RJ (1995). Gastric carcinoma. New Engl J Med, 6, 32-41.
19. Ghadimi R, Taheri H, Suzuki S, et al (2007). Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev, 16, 192-5.
20. Haruma K (2000). Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in Japan. Gastroenterol Clin North Am, 29, 623-31.
21. He Y T, Hou J, Chen Z, et al (2008). Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur J Cancer Prev, 17, 71-6.
22. Hossein N (2010). Helicobacter pylori and gastric cancer in the Middle East: a new enigma. World J Gastroenterol, 14, 3224-36.
23. Igissinov S, Igissinov N, Moore MA, et al (2011). Trends of prevalent cancer incidences in the Aral-Syr darya ecological area of Kazakhstan. Asian Pacific J Cancer Prev, 12, 2299-303.
24. Jung K, Won Y (2005). Cancer statistics in Korea: incidence, mortality and survival in 2005. JKMS, 24, 995-03.
25. Kaneko S, Yoshimi I (2003). Mortality trend of stomach cancer in Japan: 1960-2000. Jpn J Clin.Oncol,33, 105-6.
26. Kaneko S,Yoshimura T (2001). Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer, 84, 400-5.
27. Katz L, Steinitz R (1979). Cancer patterns in Israel: selected aspects. Isr J Med Sci, 15, 983-9.
28. Kim M K, Sasaki S, Sasazuki S, et al (2004). Prospective study of three major dietary patterns and risk of gastric cancer in Japan. Int J Cancer, 110, 435-42.
29. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
30. Lambert R, Guilloux A, Oshima A, et al (2002). Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer, 97, 811-8.
31. Malekzadeh R, Derakhshan M, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
32. Malekzadeh R, Sotoudeh M, Derakhshan M, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol, 57, 37-42.
33. Marmot M, Atinmo T, Byers T (2007). Food, nutrition, physical activity, and the prevention of cancer: a global perspectiver. AICR, Washington.
34. Matsuzaka M, Fukuda S, Takahashi I, et al (2007). The decreasing burden of gastric cancer in Japan. Tohoku J Exp Med, 3, 207-19.
35. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12,15-23.
36. Moghimi-Dehkordi B, Safaee A, Vahedi M, et al (2011). Familial prevalence of cancer in Iran: a general population estimate. Asian Pacific J Cancer Prev, 12, 289-95
37. Moore M A, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pacific J Cancer Prev, 11, 17-32.
38. Mousavi S M, Gouya M M, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
39. Najafi F, Mozaffari HR, Karami M, et al (2011). Trends in incidence of gastrointestinal tract cancers in Western Iran, 1993-2007. Iran Red Crescent Med J, 13, 805-10
40. Nooyi SC, Al-Lawati JA (2011). Cancer incidence in Oman, 1998-2006. Asian Pacific J Cancer Prev, 12, 1735-9.
41. Parkin D M, Pisani P, Ferlay J (1980). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 15, 827-41.
42. Parkin DM, Bray F, Ferlay J (1999). Global cancer statistics. CA Cancer J Clin, 55, 33-64.
43. Pinheiro P, Teyczinski J (2003). Cancer incidence and mortality in Portugal. EJC, 39, 2507-20.
44. Pirzadeh A, Doustmohammadian N, Khoshbaten M, et al (2011) . Is there any association between Helicobacter pylori infection and laryngeal carcinoma? Asian Pacific J Cancer Prev, 12, 897-900.
45. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Erratum: estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 12, 870-73.
46. Pisani P, Parkin DM, Muñoz N, Ferlay J (1997). Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol, 10, 387-98.
47. Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R (2009). The role of diet and other environmental factors in the causation of gastric cancer in Iran-a population based study. Int J Cancer, 125, 1953-60.
48. Rafsanjani FN, Maghouli F, Vahedian J, Esmaeili F (2004). The effects of chronic consumption of heroin on basal and vagal electrical-stimulated gastric acid and pepsin secretion in rat. Saudi Med J, 25, 1356-59.
49. Roshanaei G, Ghannad MS, Jafarabadi MA, et al (2011). Prognostic impact of risk factors in patients with gastric cancer in Iran. Asian Pacific J Cancer Prev, 12, 3005-7.
50. Sadjadi A, Hislop T G, Gregory T, et al (2009). Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer, 9, 381-9.
51. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2006). Cancer occurrence in Iran in 2002, an international perspective. Asian Pacific J Cancer Prev, 6, 359-63.
52. Sasazuki S, Sasaki S, Tsugane S (2002). Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer, 101, 560-6.
53. Sjödahl K, Lu Y, Nilsen TI, et al (2007). Smoking and alcohol drinking in relation to risk of gastric cancer: a populationbased, prospective cohort study. Int J Cancer, 1, 128-32.
54. Terry P, Lagergren J, Hansen H, Wolk A, Nyrén O (2001). Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev, 4, 365-9.
55. Tomatis L, Aitio (1990). Cancer: causes, occurrence and control. IARC, Lyon, France.
56. Tsugane S (2005). Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci, 96, 1-6.
57. Yavari P, Sadrolhefazi B, Mohagheghi MA, et al (2008). An epidemiological analysis of cancer data in an Iranian hospital during the last three decades.Asian Pacific J Cancer Prev, 9, 145-50.
58. Yazdizadeh B, Jarrahi AM, Mortazavi H, et al (2006). Time trends in the occurrence of major GI cancers in Iran. Asian Pacific J Cancer Prev, 6,130-4.